Document is current
Any future updates will be listed below
-
Authors
Padilla, Angel M. http://orcid.org/0000-0002-7907-5667
Wang, Wei
Akama, Tsutomu http://orcid.org/0000-0003-3164-9147
Carter, David S.
Easom, Eric
Freund, Yvonne http://orcid.org/0000-0003-0025-1400
Halladay, Jason S.
Liu, Yang http://orcid.org/0000-0003-0837-6953
Hamer, Sarah A. http://orcid.org/0000-0002-4955-048X
Hodo, Carolyn L. http://orcid.org/0000-0003-4113-7081
Wilkerson, Gregory K.
Orr, Dylan
White, Brooke http://orcid.org/0000-0002-0441-1355
George, Arlene http://orcid.org/0000-0003-0844-088X
Shen, Huifeng
Jin, Yiru http://orcid.org/0000-0002-0392-6824
Wang, Michael Zhuo http://orcid.org/0000-0003-2494-4172
Tse, Susanna
Jacobs, Robert T. http://orcid.org/0000-0001-9669-2862
Tarleton, Rick L. http://orcid.org/0000-0002-9589-5243
-
Funding
Funding for this research was provided by:
Wellcome Trust
- License Information
-
More Information
Article History
Received: 28 December 2021
Accepted: 21 July 2022
First Online: 5 September 2022
Competing interests
: The University of Georgia Research Foundation, Inc. has a financial interest in the intellectual property (IP) detailed in the manuscript including the candidate compounds. Authors from the University of Georgia may receive personal compensation and research funding as governed by the University of Georgia IP Policy if the IP is licensed for commercial use. Authors formerly employed by Anacor Pharmaceuticals or Pfizer were paid employees and shareholders of Anacor/Pfizer and T.A., D.S.C., J.S.H., R.T.J. and Y.L. are named inventors on issued patents. The other authors declare no competing interests.
